医学
血管瘤
婴儿血管瘤
腰椎
放射科
儿科
外科
重症监护医学
出处
期刊:PubMed
日期:2023-08-06
卷期号:57 (8): 1286-1291
标识
DOI:10.3760/cma.j.cn112150-20220826-00844
摘要
Infantile hemangiomas (IHs) are benign vascular tumors commonly observed in children. It is important to familiar with the characteristic features of hemangioma before diagnosis. Lesions located special position including periorbital and beard region, segmental hemangioma related PHACE syndrome and LUMBAR syndrome, hepatic hemangioma and related possible risks should be recognized. Early evaluation and assessment of risk grades should be done as early as possible before proliferation phase, so as to choosing the optimal treatment opportunity and scheme. β-blockers are the mainstay of therapy for moderate-to-high risk hemangiomas nowadays. Early initiation of treatment can prevent adverse complications and achieve the best outcome. During the diagnosis and treatment of infantile hemangioma, it emphasizes updating of the concept of naming and classification, treatment timing control and therapeutic scheme selection. Standardized clinical diagnosis and treatment should be promoted currently.婴幼儿血管瘤是最常见的血管肿瘤,把握其临床特征是诊断的重要依据,需注意识别特殊部位血管瘤包括眶周和胡须部位血管瘤、节段型血管瘤相关的PHACE综合征和LUMBAR综合征、肝血管瘤及相关可能风险。增殖期前尽早评估并判断风险等级对于正确选择治疗时机和方法至关重要。β受体阻滞剂是现今中高风险血管瘤的主流治疗方法,尽早开始使用可防止发生并发症并获得最佳结局。强调婴幼儿血管瘤诊疗中关于命名和分类、治疗时机把控、治疗方法选择等理念的更新,推动临床规范诊疗。.
科研通智能强力驱动
Strongly Powered by AbleSci AI